BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18636147)

  • 1. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
    Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
    Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
    Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
    Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma.
    Prat E; Bernués M; Del Rey J; Camps J; Ponsa I; Algaba F; Egozcue J; Caballín MR; Gelabert A; Miró R
    Cancer Genet Cytogenet; 2006 Jan; 164(2):142-7. PubMed ID: 16434318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.
    Schmidt L; Junker K; Weirich G; Glenn G; Choyke P; Lubensky I; Zhuang Z; Jeffers M; Vande Woude G; Neumann H; Walther M; Linehan WM; Zbar B
    Cancer Res; 1998 Apr; 58(8):1719-22. PubMed ID: 9563489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours.
    Fischer J; Palmedo G; von Knobloch R; Bugert P; Prayer-Galetti T; Pagano F; Kovacs G
    Oncogene; 1998 Aug; 17(6):733-9. PubMed ID: 9715275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
    Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
    Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological significance of c-met over expression in papillary renal cell carcinoma.
    Sweeney P; El-Naggar AK; Lin SH; Pisters LL
    J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
    Schmidt LS; Nickerson ML; Angeloni D; Glenn GM; Walther MM; Albert PS; Warren MB; Choyke PL; Torres-Cabala CA; Merino MJ; Brunet J; Bérez V; Borràs J; Sesia G; Middelton L; Phillips JL; Stolle C; Zbar B; Pautler SE; Linehan WM
    J Urol; 2004 Oct; 172(4 Pt 1):1256-61. PubMed ID: 15371818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas.
    Zhuang Z; Park WS; Pack S; Schmidt L; Vortmeyer AO; Pak E; Pham T; Weil RJ; Candidus S; Lubensky IA; Linehan WM; Zbar B; Weirich G
    Nat Genet; 1998 Sep; 20(1):66-9. PubMed ID: 9731534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
    Lubensky IA; Schmidt L; Zhuang Z; Weirich G; Pack S; Zambrano N; Walther MM; Choyke P; Linehan WM; Zbar B
    Am J Pathol; 1999 Aug; 155(2):517-26. PubMed ID: 10433944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signature-based analysis of MET proto-oncogene mutations using DHPLC.
    Nickerson ML; Weirich G; Zbar B; Schmidt LS
    Hum Mutat; 2000; 16(1):68-76. PubMed ID: 10874308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel germ line juxtamembrane Met mutation in human gastric cancer.
    Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
    Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutation of the MET gene detected in human glioma.
    Moon YW; Weil RJ; Pack SD; Park WS; Pak E; Pham T; Karkera JD; Kim HK; Vortmeyer AO; Fuller BG; Zhuang Z
    Mod Pathol; 2000 Sep; 13(9):973-7. PubMed ID: 11007037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene.
    Glukhova L; Lavialle C; Fauvet D; Chudoba I; Danglot G; Angevin E; Bernheim A; Goguel AF
    Oncogene; 2000 Feb; 19(6):754-61. PubMed ID: 10698493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
    Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
    Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic bilateral papillary renal carcinoma exhibiting C-met mutation in the left kidney tumor.
    Takaki Y; Furihata M; Yoshikawa C; Kishida T; Yao M; Shuin T
    J Urol; 2000 Apr; 163(4):1241-2. PubMed ID: 10737508
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
    Lorenzato A; Olivero M; Patanè S; Rosso E; Oliaro A; Comoglio PM; Di Renzo MF
    Cancer Res; 2002 Dec; 62(23):7025-30. PubMed ID: 12460923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
    Miyata Y; Kanetake H; Kanda S
    Clin Cancer Res; 2006 Aug; 12(16):4876-81. PubMed ID: 16914575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.